Brainstorm Cell Therapeutics (BCLI) Stock Chart & Stock Price History $1.19 -0.07 (-5.56%) Closing price 04:00 PM EasternExtended Trading$1.24 +0.05 (+4.12%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Brainstorm Cell Therapeutics Stock Price Performance 5 Day Performance-11.85%1 Month Performance-25.63%3 Month Performance-47.58%6 Month Performance-63.38%Year-To-Date Performance-47.58%1 Year Performance-89.28% Receive BCLI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address BCLI Stock Chart for Tuesday, April, 1, 2025 BCLI Chart by TradingViewRemove Ads Brainstorm Cell Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/01/2025$1.26$1.19-5.56%$1.25$1.1728,292 shs$6.79 million03/31/2025$1.19$1.26+5.88%$1.28$1.1270,818 shs$7.19 million03/28/2025$1.35$1.19-11.85%$1.35$1.1885,025 shs$6.79 million03/27/2025$1.40$1.35-3.57%$1.42$1.3416,344 shs$7.70 million03/26/2025$1.44$1.40-2.78%$1.59$1.3941,222 shs$7.98 million03/25/2025$1.37$1.44+5.11%$1.56$1.3728,647 shs$8.21 million03/24/2025$1.41$1.37-2.84%$1.45$1.3531,674 shs$7.81 million03/21/2025$1.54$1.41-8.44%$1.53$1.37129,307 shs$8.04 million03/20/2025$1.56$1.54-1.28%$1.58$1.5012,827 shs$8.78 million03/19/2025$1.55$1.56+0.65%$1.60$1.5386,617 shs$8.90 million Get the Latest News and Ratings for BCLI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/18/2025$1.58$1.55-1.90%$1.60$1.537,404 shs$8.84 million03/17/2025$1.59$1.58-0.63%$1.64$1.5817,083 shs$9.01 million03/14/2025$1.56$1.59+1.92%$1.64$1.589,670 shs$9.07 million03/13/2025$1.57$1.56-0.64%$1.69$1.559,565 shs$8.90 million03/12/2025$1.64$1.57-4.27%$1.70$1.5724,899 shs$8.95 million03/11/2025$1.63$1.64+0.61%$1.69$1.6115,693 shs$9.35 million03/10/2025$1.65$1.63-1.21%$1.69$1.5537,109 shs$9.30 million03/07/2025$1.59$1.65+3.77%$1.65$1.5621,931 shs$9.41 million03/06/2025$1.58$1.59+0.63%$1.65$1.5514,387 shs$9.07 million03/05/2025$1.50$1.58+5.05%$1.70$1.5514,058 shs$9.01 million03/04/2025$1.56$1.50-3.59%$1.56$1.5010,575 shs$8.58 million03/03/2025$1.60$1.56-2.50%$1.65$1.5512,119 shs$8.90 million02/28/2025$1.58$1.60+1.27%$1.66$1.5727,109 shs$9.13 million Related Companies RLYB Stock Chart GBIO Stock Chart CLNN Stock Chart CGTX Stock Chart TENX Stock Chart CALC Stock Chart DARE Stock Chart DRRX Stock Chart PULM Stock Chart GDTC Stock Chart Receive BCLI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Brainstorm Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BCLI) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainstorm Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
